Replies to post #1925 on GTC Biotherapeutics (fka GTCB)

[biopearl]

Dew, Thrombate III mailing received today as direct marketing for this agent. This is a plasma derived agent by Talecris, but you know that. I have never seen this before directly marketed to docs. The potential to transmit infections including hep C is noted in precautions. This means to me they feel the pressure of oncoming competition. Its good for us, let them develop the market! Their blurb: "One per 2000 people in the general population has hereditary antithrombin III deficiency. One therapy is FDA approved to treat it. Ask us about Thrombate III (Antithrombin III (human)). Restoring the balance in hemostasis"...etc, etc. INTERESTING!! Regards to all,, bp

[CapraVacca]

O I'm sorry i used the question from message #1918

I was watching Top Gear on the TV and reading this board, as well the board in the Netherlands where someone posted the link to this report.
It seems that I'm not so good at doing two things at once -))

But it's the whole report.

Grtz CV